MyMD Pharma Stock Is Trading Higher As COVID-19 Candidate Effective In Suppressing Cytokine Storm
MyMD Pharmaceuticals Inc (NASDAQ:MYMD) announces that a human cell research study of its lead compound MYMD-1 found the drug to…
MyMD Pharma Reports Its Lead Compound MYMD-1 Shown To Suppress Major Cause Of Death In COVID-19 In Human Cell Study
MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic
MyMD Pharma Highlights New Data From Study Conducted By Eurofins Discovery Phenotypic Center Of Excellence Comparing Biological Activities Of Co.’s Lead Compound MYMD-1
New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs
Company plans to initiate Phase II trial with a leading academic institution
BALTIMORE--(BUSINESS WIRE)-- MyMD